MD

Mukesh Dalchand Agrawal

Director DIN 06370968
DIN 06370968 First appointment Jan 2007
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Dalchand Agrawal

Data last updated:

Mukesh Dalchand Agrawal was a Director at Hanuman Proteins Private Limited (from 2007) and Director at Kanhaiyya Dal & Oil Industries Private Limited (from 2012).

DIN 06370968
First Appointment 19 Jan 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hanuman Proteins Private Limited U74999MH2007PTC167154
Director19 Jan 20072007Strike Off
Director10 Sep 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hanuman Proteins Private Limited
Kanhaiyya Dal & Oil Industries Private Limited
Premium access

Shareholding and investment profile for Mukesh Dalchand Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Dalchand Agrawal

Mukesh Dalchand Agrawal was first appointed on 19 Jan 2007 as Director at Hanuman Proteins Private Limited. The most recent appointment on record is 10 Sep 2012 at Kanhaiyya Dal & Oil Industries Private Limited.

Mukesh Dalchand Agrawal held 2 earlier board appointments: Hanuman Proteins Private Limited (Director, from 19 Jan 2007); Kanhaiyya Dal & Oil Industries Private Limited (Director, from 10 Sep 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available